No retraction, correction or concern found when last checked on Oct 17, 2026.
Rolling Circle Translation of Circular RNA in Living Human Cells
Naoko Abe, Ken Matsumoto, Mizuki Nishihara and 8 more
Scientific Reports · 2015 · CC BY
Abstract
We recently reported that circular RNA is efficiently translated by a rolling circle amplification (RCA) mechanism in a cell-free Escherichia coli translation system. Recent studies have shown that circular RNAs composed of exonic sequences are abundant in human cells. However, whether these circular RNAs can be translated into proteins within cells remains unclear. In this study, we prepared circular RNAs with an infinite open reading frame and tested their translation in eukaryotic systems. Circular RNAs were translated into long proteins in rabbit reticulocyte lysate in the absence of any particular element for internal ribosome entry, a poly-A tail, or a cap structure. The translation systems in eukaryote can accept much simpler RNA as a template for protein synthesis by cyclisation. Here, we demonstrated that the circular RNA is efficiently translated in living human cells to produce abundant protein product by RCA mechanism. These findings suggest that translation of exonic circular RNAs present in human cells is more probable than previously thought.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 17, 2026. Paragraph numbers are ours, so an answer can point at one.
We recently found that circular RNA containing an infinite open reading frame (ORF) can be efficiently translated to produce proteins in an Escherichia coli cell-free translation system, in a manner similar to rolling circle amplification (RCA) of the polymerase reaction (Fig. 1). In this translation system, the circular RNA contains no stop codon and the number of nucleotides composing the RNA is a multiple of three. Thus, theoretically, the elongation process can last indefinitely once translation initiation occurs. The mechanism of RCA not only provides a long-repeating peptide sequence but also enhances the productivity over a given period of time, because the ribosome does not need to bind multiple times with the RNA template, which is the rate limiting step in the reaction cycle. In our case, the circular template produced translation product two orders of magnitude more efficiently than its linear counterpart.
In the present study, we applied circular RNA to eukaryotic translation systems, which are more complex than those in prokaryotes. Synthesis of protein via RCA has not previously been reported in living eukaryotic cells; therefore, we posed the question of whether this is possible. In 1979, circular RNA was found to bind to prokaryotic but not eukaryotic ribosomes. To the best of our knowledge, translation of circular RNA in the absence of any particular element for internal ribosome entry has never been reported in eukaryotic systems. In general, the majority of eukaryotic messenger RNAs (mRNAs) possess a 5′ cap structure and a 3′ poly(A) tail. Eukaryotic translation initiation is normally cap-dependent, because recognition of the cap is required for assembly of the initiation complex. Cap-independent translation is an alternative means of translation initiation in eukaryotes that depends on the presence of particular elements that induce internal initiation, such as an internal ribosome entry site (IRES). IRES sequences were first reported in viral RNAs, and bind to eukaryotic ribosomes when internal to the RNA. In principle, the key feature of IRES-driven translation is its 5′-end independence, rather than cap-independence.
In this study, we show for the first time that circular RNA synthesised in vitro can be translated in living human cells in the absence of particular elements for internal initiation. Moreover, we show that protein could be synthesised from circular RNA via the RCA mechanism in eukaryotic translation systems (Fig. 1).
Results
First of all, small circular RNAs of 129, 258 and 387 nucleotides, which contain multiple FLAG-coding sequences, were synthesised (Figs 2A and 3 and Supplementary Table S1). The FLAG peptide consists of eight amino acids (Asp Tyr Lys Asp Asp Asp Asp Lys), and is thus encoded by a sequence of 24 nucleotides (nt). The minimum length of the RNA circles used in this study was set as 129 nt, based on the previous finding that a circular RNA of 126 nt with multiple FLAG-coding sequences was well translated in an E. coli cell-free system. These circular RNAs contained an infinite ORF but no particular sequence for internal initiation. In eukaryotes, the RNAs included the Kozak consensus sequence, GCCAUGG, which contained an initiation codon, and the conserved flanking nucleotides (Fig. 3). The Kozak sequence plays a major role in initiation of translation in eukaryotic systems. A circular RNA of 129 nt named 4× FLAG contained four FLAG coding sequences. Larger circular RNAs of 258 nt and 387 nt, named 8× and 12× FLAG, contained eight and twelve FLAG coding sequences, respectively. AU-rich spacer sequences, such as AUCAUC, are selected between the FLAG-coding sequences to suppress undesired secondary structure formation in the RNA, which might inhibit its translation. Precursor linear RNAs were transcribed in vitro from their dsDNA templates (Supplementary Table S2) using T7 RNA polymerase (Supplementary Fig. S1). Guanosine monophosphate was added to the reaction mixture in order to phosphorylate the transcribed RNAs at the 5′-end, which was required for the subsequent circularization reaction. After purification, the linear transcribed RNAs were circularised using T4 RNA ligase 2 with a short complementary DNA sequence as the template (Fig. 2A, Supplementary Fig. S1). Circularity of synthesized RNAs were confirmed using RNase R, an 3′−5′ exoribonuclease (Fig. 2B).
In the first set of experiments, these linear and circular RNAs were tested for translation using a cell-free rabbit reticulocyte lysate system (RRL). After incubation, the reaction mixtures were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blot analysis using an anti-FLAG M2 antibody (Fig. 3C). When the 8× and 12× FLAG linear RNAs were incubated, bands smaller than 25 kDa were observed (Supplementary Fig. S2). To suppress the background signal, the lysates were purified using anti-FLAG M2 antibody-conjugated agarose beads prior to analysis. It is known that uncapped mRNA can also be translated by a 5′ end-dependent scanning mechanism. When circular RNAs were incubated with the lysate, high-molecular weight smears could be seen just below the top of the gel, suggesting that translation had been initiated and continued on the circle. Of the three RNA circles evaluated, the 8× FLAG circular RNA produced the most high-molecular weight peptides. Assuming the molecular weight of the repeating product to be more than 300 kDa, the ribosomes would have cycled around the circle at least 15 times, based on a product of 20 kDa translated from the linear counterpart of the circular RNA (Fig. 3C and Supplementary Fig. S2).
Next, we exogenously introduced these circular RNAs into HeLa cells, a human epithelial cell line derived from a cervical adenocarcinoma, to determine whether they were translated. By western blot analysis of the HeLa cell lysate, FLAG-containing peptides of high-molecular weight were detected from the 8× FLAG circular RNA (Fig. 4A). HeLa cells transfected with RNAs were then immunostained and observed by fluorescence microscopy (Fig. 4B). Fluorescent dots were visible throughout the cytoplasm of cells transfected with 8× FLAG linear RNA, whereas no signal was detected in mock-transfected cells. More signals of higher intensity were seen in cells transfected with the circular RNA compared with the linear RNA, indicating that the amount of translation product was greater from the circular RNA. The smaller 4× FLAG circular RNA also produced fluorescent signals in HeLa cells (Supplementary Fig. S3).
At this point, we performed a control experiment to investigate whether the repeating FLAG-coding sequence itself possessed IRES activity (Fig. 5). We prepared a series of plasmid DNA vectors containing two reporter genes, chloramphenicol acetyltransferase (CAT) and β-galactosidase (β-gal) (Fig. 5A). To assess its IRES activity, the 4× FLAG sequence was inserted between the two cistrons to generate the vector, pβGal–4× FLAG–CAT, and the expression of CAT from the second cistron was compared with CAT expression from a control vector without an IRES (pβGal–CAT) and a vector containing an encephalomyocarditis (EMCV) IRES (pβGal–IRES–CAT). The expression levels of β-gal and CAT are shown in Fig. 5B and C, respectively. As shown in Fig. 5D, pβGal–4× FLAG–CAT showed no substantial IRES activity, because its relative CAT/βGal expression level was comparable to that of pβGal–CAT, the control vector. Based on these results, we conclude that the translation initiation on these circular RNAs is unlikely to be attributed to an IRES activity of FLAG–coding sequences.
To obtain some mechanistic insight into translation of circular RNAs, five different circular RNAs were synthesised (Fig. 6A, Supplementary Fig. S4, Supplementary Tables S3 and S4). Circular RNAs coding for human epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1) or insulin-like growth factor-2 (IGF-2), positioned just downstream of a Kozak sequence and FLAG-coding sequences were prepared, and their translation in RRL was compared (Fig. 6B; FLAG-EGF, FLAG-IGF1 and FLAG-IGF2, respectively). Strong signal just below the top of the gel, which indicates that translation initiation had occurred and that the elongation reaction had cycled around the circle, was observed only when a circular RNA FLAG-EGF was tested (Fig. 6B). It is likely that the translation initiation occurred on the other two circular RNAs, FLAG-IGF1 and FLAG-IGF2, because their translation products at around 20–25 kDa seem to be longer than those of the linear RNA (Fig. 6B). One possibility is that differences in secondary structures affected the translation reaction. The coding region for EGF contained the fewest GC nucleotides among the three (55% for EGF, 59% for IGF-1 and 66% for IGF-2, Supplementary Table S3). These circular RNAs produced peptides of high molecular weight in an E. coli cell-free translation system upon incubation, as well as in RRL (Supplementary Fig. S5). In the prokaryotic system, circular FLAG-EGF was also most efficiently translated among the three circular RNAs. As shown in Fig. 6C, no translation product was observed from circular RNA FLAG-EGF_stop, which contained stop codons, and thus a finite ORF in the sequence. The translation product from the circular FLAG-EGF was also detected using anti-EGF antibody, not only by anti-FLAG antibody (right panel of Fig. 6C). We then examined whether the strength of the Kozak consensus sequence has an effect on translation of circular RNA. The Kozak sequence within FLAG-EGF was mutated to a weaker, less-effective sequence (Fig. 6A and Supplementary Table S3, FLAG-EGF_weak kozak). As shown in Fig. 6D, the circular RNA with the weaker Kozak sequence also produced translation product just below the top of the gel. Decrease in the intensity of the product when compared with that from a circular RNA with the optimum Kozak sequence indicates that this mutation reduced the efficiency of translation initiation. As also seen in a prokaryotic system, however, when initiation has occurred once on a circular RNA with an infinite ORF, even if the initiation is ineffective, the elongation process can revolve around the circle multiple times producing high-molecular weight proteins.
Discussion
In eukaryotic translation systems, it was thought that circular mRNA can be translated only if it contains a sequence for internal ribosome entry. However, in this study, we demonstrated that circular RNA can be translated without such particular sequences, even in living human cells. The translatable circular RNAs used in this study contained repeated FLAG-coding sequences. We can attribute the detection of the translation product to the highly sensitive FLAG system. However, more importantly, based on the result shown in Fig. 6C, the RCA mechanism was essential for the detection of translation initiation on circular RNA, which is usually quite inefficient. As for the importance of the Kozak consensus sequence for the initiation of translation on circular RNA, only a moderate reduction in the amount of translation product was observed when the optimal Kozak sequence was mutated to a weaker one. This result might indicate that the flanking sequences of an initiation codon do not strongly influence the translation of circular RNA by the RCA mechanism.
Recent studies have shown that circular RNAs composed of exonic sequences are abundant in human cells. Previous knowledge of exonic circular RNA was limited to a handful of genes, and circular RNAs were thought to be an exceptional species produced by missplicing events. However, high-throughput sequence analysis of the transcriptome has revealed that circular RNAs are conserved and more prevalent in eukaryotes than previously thought. For instance, it has been reported that circular RNA molecules emanate from >14% of transcribed genes in human fibroblast cells. Endogenous circular RNAs were shown to function as post-transcriptional regulators, for example as competitive inhibitors for microRNAs, known as microRNA sponges. Our results indicate that circular RNA molecules can be translated into protein even without any IRES sequence, poly A or cap structure.
In conclusion, we demonstrated that circular RNA with an infinite ORF is a substrate for RCA of peptide in living human cells. Because endogenous circular RNAs are known to be abundant in human cells and may be translated into proteins, we are now examining whether endogenous circular RNAs can be translated in mammalian translation systems.
Denaturing polyacrylamide gel electrophoresis (PAGE) of RNA
Enzymatic reactions were analysed by denaturing PAGE [4–8% polyacrylamide (acrylamide/N, N′-methylenebisacrylamide, 19:1), 7.5 M urea, 25% (v/v) formamide, 89 mM Tris, 89 mM boric acid, 2 mM EDTA]. The RNA samples were mixed with equal amount of 2× formamide loading solution [80% (v/v) formamide, 10 mM EDTA pH 8.0, 0.1 mg/mL xylene cyanol FF, 0.1 mg/mL bromophenol blue], and heated at 90 °C for 3 min before being loaded on the gel. The gels were electrophoresed and stained with SYBR Green II (Lonza) and visualised on a BioRad ChemiDoc XRS+ System (BioRad, Hercules, CA, USA), Luminescent Image Analyser LAS 4000 (Fujifilm, Tokyo, Japan) or FAS-IV Imaging System (Nippon Genetics, Tokyo, Japan). Low Range ssRNA Ladder (New England Biolabs, Ipswich, MA, USA) was used as the size marker. RNAs were also purified by preparative denaturing PAGE. The RNA bands were visualised by UV shadowing, and crushed and extracted with water. The extracts were desalted by centrifugation with Amicon Ultra-0.5 mL or Amicon Ultra-4 mL centrifugal filter unit (Millipore, Billerica, MA, USA), according to the manufacturer’s instructions. The RNAs were then precipitated with sodium acetate (pH 5.2) and 2-propanol.
Synthesis of linear RNAs by in vitro transcription
Linear RNAs were transcribed in vitro by T7 RNA polymerase from corresponding dsDNA templates (Supplementary Tables S2 and S4). The dsDNA templates for 4×, 8× and 12× FLAG RNA were synthesised in our laboratory. The DNA templates for FLAG-EGF, FLAG-IGF1, FLAG-IGF2 and FLAG-EGF_weak kozak were synthesised by Integrated DNA technologies, Inc (Coralville, IA, USA). The DNA sequence was amplified by PCR using PrimeSTAR HS DNA Polymerase (Takara Bio, Shiga, Japan: 0.01 ng/μL DNA vector, 1× PrimeSTAR buffer, 0.2 mM dNTPs, 1.5 μM primers, 0.025 units/μL polymerase). Linear RNA strands were prepared from the PCR products by in vitro transcription. Linear RNAs were prepared using the MEGAscript High Yield Transcription Kit (Invitrogen by Thermo Fisher Scientific, Waltham, MA, USA) except 4× FLAG linear RNA, which was transcribed using T7 polymerase obtained from Takara Bio. 5′-mono-phosphorylated in vitro transcripts were obtained by adding an excess amount of GMP (7.5 mM) to GTP (1.5 mM) in the reaction mixture. Based on the efficiency of the subsequent circularisation reaction, most of the transcription reaction appeared to be primed from GMP. After incubation, the reaction was treated with DNase to remove the DNA template. The transcribed RNAs were purified by preparative 5% denaturing PAGE.
Circularisation of linear RNA using T4 RNA ligase 2
Transcribed linear RNA was circularised using T4 RNA ligase 2 (New England Biolabs) on a 20-nt DNA oligomer (guide DNA) as template (Supplementary Figs. S1 and S4). After annealing with a guide DNA (3–5 μM), 1 μM linear RNA was incubated with 0.0125 U/μL T4 RNA ligase 2 in a mixture of 50 mM Tris-HCl (pH 7.5), 2 mM MgCl2, 1 mM DTT and 0.4 mM ATP at 37 °C for 3 h. The ligated products were purified by preparative 5 or 6% denaturing PAGE.
Circularity check of the RNA using RNase R
RNA (0.04 μg/μL) was incubated with RNase R (1 unit/μL; Epicenter, Madison, WI, USA) in 20 mM Tris-HCl (pH 8.0), 0.1 M KCl, and 0.1 mM MgCl2 at 37 °C for 10 min. The reaction mixture (5 μL) was analysed by 6% denaturing PAGE.
Western blot analysis of the translation reaction of circular RNA in rabbit reticulocyte lysate
Circular RNA was incubated for 5 h or overnight in rabbit reticulocyte lysate (Promega, Fitchburg, WI, USA) at 30 °C in a volume of 20–25 μL. The final composition of the reaction mixture contained 70% rabbit reticulocyte lysate, 10 μM methionine and leucine, 20 μM amino acids other than methionine and leucine, 0.8 U/μL RNase inhibitor (Toyobo, Osaka, Japan). Aliquots (2.5 μL) were taken from the mixture and separated on 10–20% gradient polyacrylamide/sodium dodecyl sulfate (SDS) gels (Atto, Tokyo, Japan). As for the experiments shown in Fig. 6, acetic acid (0.32 μL) and water (300 μL) were added subsequently to the reaction mixture (16 μL) and it was centrifuged at 20,817× g for 10 min at 15 °C. The supernatant was removed and the pellet was dissolved in 30 μL of 2× SDS sample buffer (0.125 M Tris-HCl, pH 6.8, 4% SDS, 30% glycerol, 5% 2-mercaptoethanol, 0.01% bromophenol blue) at 70 °C for 15 min. The majority of the hemoglobin protein was removed during this process whereas proteins other than hemoglobin were concentrated (this purification procedure was provided by the technical service division of Promega). After centrifugation at 1,400× g for 5 min, the supernatant (10 μL) was analysed on 10–20% gradient polyacrylamide/ SDS gels. The Precision Plus Protein Kaleidoscope Standard (BioRad) was used as the size marker. After being electrotransferred to a polyvinylidene fluoride (PVDF) membrane (Millipore) using the semi-dry method, the blot was incubated with an anti-FLAG M2 monoclonal antibody (Sigma-Aldrich, St. Louis, MO, USA) and anti-mouse IgG peroxidase conjugate (Sigma-Aldrich). Anti-EGF, anti-IGF1, anti-IGF2 were also used as the primary antibodies (Santa Cruz Biotech.) The blot was visualised using the SuperSignal West Femto Maximum Sensitivity Substrate Kit (Thermo Fisher Scientific, Waltham, MA, USA) on a Light-Capture cooled CCD camera system (Atto) or on a Luminescent Image Analyser LAS 4000 (Fujifilm).
Western blot analysis of the translation reaction in cultured human cells
HeLa cells (RIKEN Cell Bank, Ibaraki, Japan) were grown in Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) supplemented with 10% fetal bovine serum (FBS; Invitrogen) at 37 °C under 5% CO2. Cells were passaged regularly to maintain exponential growth. Lipofectamine RNAiMAX (2 μL; Invitrogen) was added to a mixture of 1 μg RNA and 145 μL Opti-MEM I solution (Invitrogen) in a well of a 12-well plate. After incubation at room temperature for 15 min, 8.5 × 104 HeLa cells suspended in DMEM containing 10% FBS (0.85 mL) were added to the RNA solution. After incubation for 24 h at 37 °C, the cells were collected and lysed with 0.2 mL of 1× Cell Lysis Buffer (Cell Signaling Technology, Danvers, MA, USA) containing 100 mM phenylmethylsulfonyl fluoride (Thermo Fisher Scientific). The lysates (7.5 μL) were subjected to SDS-PAGE (10–20% gradient gel, Atto) and western blot analysis as described above.
Immunocytochemistry of the translation products in cultured human cells
HeLa cells were grown in DMEM supplemented with 10% FBS at 37 °C under 5% CO2. Cells were passaged regularly to maintain exponential growth. One day before transfection, cells were inoculated in a 24-well plate with a glass coverslip at the bottom of the wells. RNA (1 μg) was transfected into the cells using the transfection reagent, Oligofectamine (Invitrogen), according to the manufacturer’s instructions. After incubation for 24 h at 37 °C, the cells were fixed using 4% paraformaldehyde in phosphate-buffered saline (PBS) at room temperature for 30 min and then incubated with 0.3% Triton X-100 in PBS. After blocking with 1% bovine serum albumin (BSA) in PBS, the cells were incubated with 2 μg/mL of anti-FLAG M2 monoclonal antibody (Sigma-Aldrich) in PBS containing 1% BSA for 1 h. The cells were washed twice with PBS containing 0.3% Triton X-100 and then incubated with a mixture of Alexa Fluor 488-labelled anti mouse IgG antibody (Invitrogen) and 4′,6-diamidino-2-phenylindole (DAPI; 250 ng/mL) for 30 min. The cells were mounted on a glass slide using PermaFluor aqueous mounting medium (Thermo Fisher Scientific) and examined with an inverted Olympus IX-81 fluorescence microscope (Tokyo, Japan) equipped with an oil-immersion 60× objective (1.35 N.A.).
Analysis of putative IRES activity in the FLAG-repeating sequence using a bicistronic reporter assay system
The EMCV-IRES-containing bicistronic vector, pβGal-IRES-CAT, was constructed by inserting the β-galactosidase (β-gal) gene from pCMV-LacZ Vector (Clontech, Mountain View, CA, USA) and the chloramphenicol acetyltransferase (CAT) gene from pCAT3-Basic Vector (Promega) into multi-cloning sites A and B of pIRES (Clontech), respectively. The control vector, pβGal-CAT, was obtained by removing the IRES region from the pβGal-IRES-CAT by inverse PCR. The FLAG repeat-containing vector, pβGal-4× FLAG-CAT, was constructed by inserting the 4× FLAG fragment (obtained from a vector which was synthesised at Integrated DNA Technologies Inc.) into the linker region of pβGal-CAT. The expression of the bicistronic mRNAs was driven by the cytomegalovirus (CMV) promoter. Nucleic acid sequences of vector inserts were confirmed by sequencing. HeLa cells were plated in a 6-well plate (4 × 105 cells/well, 2 mL) one day before transfection. The cells were transfected with these plasmids (2.5 μg each/well) using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. Twenty-four hours after transfection the cells were harvested and assessed for expression of β-gal and CAT by enzyme-linked immunosorbent assays (ELISA) using β-Gal ELISA and CAT ELISA kits (Roche Applied Science, Mannheim, Germany), respectively.
Additional Information
How to cite this article: Abe, N. et al.Rolling Circle Translation of Circular RNA in Living Human Cells. Sci. Rep.5, 16435; doi: 10.1038/srep16435 (2015).
References 35
- 1.
Abe N..Rolling circle amplification in a prokaryotic translation system using small circular RNA. Angew. Chem., Int. Ed. 52, 7004–7008 (2013 ).
Not in our library10.1002/anie.201302044
- 2.
Fire A. & Xu S.Q. Rolling replication of short DNA circles. Proc. Natl. Acad. Sci. USA 92, 4641–4645 (1995 ).
Not in our library10.1073/pnas.92.10.4641
- 3.
Daubendiek S.L., Ryan K. & Kool E.T. Rolling-circle RNA synthesis: circular oligonucleotides as efficient substrates for T7 RNA polymerase. J. Am. Chem. Soc. 117, 7818–7819 (1995 ).
Not in our library10.1021/ja00134a032
- 4.
Liu D.Y., Daubendiek S.L., Zillman M.A., Ryan K. & Kool E.T. Rolling circle DNA synthesis: small circular oligonucleotides as efficient templates for DNA polymerases. J. Am. Chem. Soc. 118, 1587–1594 (1996 ).
Not in our library10.1021/ja952786k
- 5.
Ali M.M..Rolling circle amplification: a versatile tool for chemical biology, materials science and medicine. Chem. Soc. Rev. 43, 3324–3341 (2014 ).
Not in our library10.1039/c3cs60439j
- 6.
Perriman R. & Ares M. Circular mRNA can direct translation of extremely long repeating-sequence proteins in vivo. RNA 4, 1047–1054 (1998 ).
Not in our library10.1017/s135583829898061x
- 7.
Chen C.Y. & Sarnow P. Initiation of protein-synthesis by the eukaryotic translational apparatus on circular RNAs. Science 268, 415–417 (1995 ).
Not in our library10.1126/science.7536344
- 8.
Jackson R.J., Hellen C.U.T. & Pestova T.V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 11, 113–127 (2010 ).
Not in our library10.1038/nrm2838
- 9.
Kozak M. Inability of circular mRNA to attach to eukaryotic ribosomes. Nature 280, 82–85 (1979 ).
Not in our library10.1038/280082a0
- 10.
Konarska M., Filipowicz W., Domdey H. & Gross H.J. Binding of ribosomes to linear and circular forms of the 5′-terminal leader fragment of tobacco-mosaic-virus RNA. Eur. J. Biochem. 114, 221–227 (1981 ).
Not in our library10.1111/j.1432-1033.1981.tb05139.x
- 11.
Perriman R. Circular mRNA encoding for monomeric and polymeric green fluorescent protein. Methods Mol. Biol. 183, 69–85 (2002 ).
Not in our library10.1385/1-59259-280-5:069
- 12.
Capel B..Circular transcripts of the testis-determining gene Sry in adult mouse testis. Cell 73, 1019–1030 (1993 ).
Not in our library10.1016/0092-8674(93)90279-y
- 13.
Makino S., Sawasaki T., Tozawa Y., Endo Y. & Takai K. Covalent circularization of exogenous RNA during incubation with a wheat embryo cell extract. Biochem. Biophys. Res. Commun. 347, 1080–1087 (2006 ).
Not in our library10.1016/j.bbrc.2006.07.011
- 14.
Jeck W.R..Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19, 141–157 (2013 ).
Not in our library10.1261/rna.035667.112
- 15.
Memczak S..Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333–338 (2013 ).
Not in our library10.1038/nature11928
- 16.
Wang Y. & Wang Z.F. Efficient backsplicing produces translatable circular mRNAs. RNA 21, 172–179 (2015 ).
Not in our library10.1261/rna.048272.114
- 17.
AbouHaidar M.G., Venkataraman S., Golshani A., Liu B.L. & Ahmad T. Novel coding, translation, and gene expression of a replicating covalently closed circular RNA of 220 nt. Proc. Natl. Acad. Sci. USA 111, 14542–14547 (2014 ).
Not in our library10.1073/pnas.1402814111
- 18.
Aitken C.E. & Lorsch J.R. A mechanistic overview of translation initiation in eukaryotes. Nat. Struct. Mol. Biol. 19, 568–576 (2012 ).
Not in our library10.1038/nsmb.2303
- 19.
Filbin M.E. & Kieft J.S. Toward a structural understanding of IRES RNA function. Curr. Opin. Struct. Biol. 19, 267–276 (2009 ).
Not in our library10.1016/j.sbi.2009.03.005
- 20.
Einhauer A. & Jungbauer A. The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. J. Biochem. Biophys. Methods 49, 455–465 (2001 ).
Not in our library10.1016/s0165-022x(01)00213-5
- 21.
Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs Nucleic Acids Res. 15, 8125–8148 (1987 ).
Not in our library10.1093/nar/15.20.8125
- 22.
Kozak M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl. Acad. Sci. USA 83, 2850–2854 (1986 ).
Not in our library10.1073/pnas.83.9.2850
- 23.
De Gregorio E., Preiss T. & Hentze M.W. Translational activation of uncapped mRNAs by the central part of human eIF4G is 5′ end-dependent. RNA 4, 828–836 (1998 ).
Not in our library10.1017/s1355838298980372
- 24.
Thompson S.R. So you want to know if your message has an IRES? WIREs RNA 3, 697–705 (2012 ).
Not in our library10.1002/wrna.1129
- 25.
Holcik M., Lefebvre C., Yeh C.L., Chow T. & Korneluk R.G. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat. Cell Biol. 1, 190–192 (1999 ).
Not in our library10.1038/11109
- 26.
Babendure J.R., Babendure J.L., Ding J.H. & Tsien R.Y. Control of mammalian translation by mRNA structure near caps. RNA 12, 851–861 (2006 ).
Not in our library10.1261/rna.2309906
- 27.
- 28.
Kozak M. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 361, 13–37 (2005 ).
Not in our library10.1016/j.gene.2005.06.037
- 29.
Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 234, 187–208 (1999 ).
Not in our library10.1016/s0378-1119(99)00210-3
- 30.
- 31.
Hansen T.B..Natural RNA circles function as efficient microRNA sponges. Nature 495, 384–388 (2013 ).
Not in our library10.1038/nature11993
- 32.
Cocquerelle C., Mascrez B., Hetuin D. & Bailleul B. Mis-splicing yields circular RNA molecules. FASEB J. 7, 155–160 (1993 ).
Not in our library10.1096/fasebj.7.1.7678559
- 33.
Hentze M.W. & Preiss T. Circular RNAs: splicing’s enigma variations. EMBO J 32, 923–925 (2013 ).
Not in our library10.1038/emboj.2013.53
- 34.
Kao C., Zheng M. & Rudisser S. A simple and efficient method to reduce nontemplated nucleotide addition at the 3′ terminus of RNAs transcribed by T7 RNA polymerase. RNA 5, 1268–1272 (1999 ).
Not in our library10.1017/s1355838299991033
- 35.
Gravel P. in The Protein Protocols Handbook, Edn. 2nd. (ed. Walker J.M. ) 321–334 (Humana Press, Totowa, New Jersey; 2002 ).
Not in our library
Cited by papers we hold 26
- Molecular mechanisms of circular RNA translation · 2024No notice
- Circular RNA vaccine in disease prevention and treatment · 2023No notice
- Ribosome biogenesis in disease: new players and therapeutic targets · 2023No notice
- Advances in Circular RNA and Its Applications · 2022No notice
- Pervasive translation of circular RNAs driven by short IRES-like elements · 2022No notice
- Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin · 2021Not checked
- Functional Roles and Biological Mechanisms of Circular RNAs and Their Encoded Peptides in Glioma: A Narrative Review · 2021Not checked
- Exploring the regulatory roles of circular RNAs in Alzheimer’s disease · 2020Not checked
- Translation and functional roles of circular RNAs in human cancer · 2020No notice
- Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA · 2020No notice
- CircRNAs: biogenesis, functions, and role in drug-resistant Tumours · 2020No notice
- Circular RNA-protein interactions: functions, mechanisms, and identification · 2020No notice
- The emerging roles and functions of circular RNAs and their generation · 2019No notice
- Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathway · 2019No notice
- Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus · 2019Corrected
- IRES-mediated cap-independent translation, a path leading to hidden proteome · 2019No notice
- The novel roles of circRNAs in human cancer · 2019No notice
- Circular RNAs: Biogenesis, Mechanism, and Function in Human Cancers · 2019No notice
- Coding or Noncoding, the Converging Concepts of RNAs · 2019No notice
- Circular RNAs as Therapeutic Agents and Targets · 2018No notice
and 6 more
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.